Loading…
Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study
Pancreatic alpha amylase (P-AMY) is used as a biomarker of acute pancreatitis (AP) in human medicine. To our knowledge, there are no studies evaluating the usefulness of P-AMY in dogs with AP. In this study, we evaluated the diagnostic value of P-AMY, currently not verified in veterinary medicine. T...
Saved in:
Published in: | The Veterinary quarterly 2024-12, Vol.44 (1), p.1-7 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c511t-cf0c418f9089f958e69953dadafd63df95713209a63e8324465732950c770b6a3 |
container_end_page | 7 |
container_issue | 1 |
container_start_page | 1 |
container_title | The Veterinary quarterly |
container_volume | 44 |
creator | Kim, Keon Kim, Hee-hong Joo, Jae-Beom Kim, Ock-Kyu Park, Sin-Wook Suh, Guk-Hyun Ro, Woong-Bin Lee, Chang-Min |
description | Pancreatic alpha amylase (P-AMY) is used as a biomarker of acute pancreatitis (AP) in human medicine. To our knowledge, there are no studies evaluating the usefulness of P-AMY in dogs with AP. In this study, we evaluated the diagnostic value of P-AMY, currently not verified in veterinary medicine. The AP group (n = 40) consisted of dogs with AP diagnosed using clinical signs and laboratory examinations, including abnormal canine pancreatic lipase (cPL) concentration, and compatible abdominal ultrasound examination at first presentation. Evaluation of the canine AP severity (CAPS) score was performed. The control group (n = 38) was composed of normal dogs without any abnormalities in clinical findings, blood exams or diagnostic imaging. The correlation of P-AMY with cPL was confirmed by Pearson's correlation analysis (r = 0.564, p |
doi_str_mv | 10.1080/01652176.2024.2326007 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_38497337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9cdcde9058724b48bd561b4d0670d34c</doaj_id><sourcerecordid>3140688584</sourcerecordid><originalsourceid>FETCH-LOGICAL-c511t-cf0c418f9089f958e69953dadafd63df95713209a63e8324465732950c770b6a3</originalsourceid><addsrcrecordid>eNp9ks1uEzEURkcIREPhEUCW2LBJsMc_Y7OhqCpQqRIbWFt3bE_i4BkHeyZVHoD3xkPSQlmwsmSfe3yv_VXVS4JXBEv8FhPBa9KIVY1rtqppLTBuHlULIhu-5IqRx9ViZpYzdFY9y3mLMcOciafVGZVMNZQ2i-rn1R7CBKOPA4odGjcOmeAHbyCgKbtuCoPLeT7awWCSK6RBEHYbQNAfAmSHICNAQ9y7gFofe0jfXUJ-QDauM7r14waBmUb3RzD6_K6U7HyII8rjZA_PqycdhOxenNbz6tvHq6-Xn5c3Xz5dX364WRpOyLg0HTaMyE5hqTrFpRNKcWrBQmcFtWWrIbTGCgR1ktaMCd7QWnFsmga3Auh5dX302ghbvUu-dHvQEbz-vRHTWkMqEwanlbHGOoW5bGrWMtlaLkjLLBYNtpSZ4np_dO2mtnfWuGFMEB5IH54MfqPXca8JVkxJyorhzcmQ4o_J5VH3PhsXAgwuTlnXqtwlCMaqoK__QbdxSkN5K00Jw0JKLmchP1ImxZyT6-67IVjPqdF3qdFzavQpNaXu1d-j3FfdxaQAF0fAD11MPdzGFKwe4RBi6lL5Vz_38d87fgHk0dIx</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3140688584</pqid></control><display><type>article</type><title>Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study</title><source>Taylor & Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Kim, Keon ; Kim, Hee-hong ; Joo, Jae-Beom ; Kim, Ock-Kyu ; Park, Sin-Wook ; Suh, Guk-Hyun ; Ro, Woong-Bin ; Lee, Chang-Min</creator><creatorcontrib>Kim, Keon ; Kim, Hee-hong ; Joo, Jae-Beom ; Kim, Ock-Kyu ; Park, Sin-Wook ; Suh, Guk-Hyun ; Ro, Woong-Bin ; Lee, Chang-Min</creatorcontrib><description>Pancreatic alpha amylase (P-AMY) is used as a biomarker of acute pancreatitis (AP) in human medicine. To our knowledge, there are no studies evaluating the usefulness of P-AMY in dogs with AP. In this study, we evaluated the diagnostic value of P-AMY, currently not verified in veterinary medicine. The AP group (n = 40) consisted of dogs with AP diagnosed using clinical signs and laboratory examinations, including abnormal canine pancreatic lipase (cPL) concentration, and compatible abdominal ultrasound examination at first presentation. Evaluation of the canine AP severity (CAPS) score was performed. The control group (n = 38) was composed of normal dogs without any abnormalities in clinical findings, blood exams or diagnostic imaging. The correlation of P-AMY with cPL was confirmed by Pearson's correlation analysis (r = 0.564, p < .001). The sensitivity and specificity for the most appropriate cut-off values of P-AMY were recorded similar to the values of DGGR. The dogs with AP and CAPS ≥11 had significantly higher serum P-AMY (p = .016) contrary to DGGR lipase and cPL. Furthermore, there was a significant difference in the median P-AMY dependent on the presence of systemic inflammatory response syndrome (p = .001). P-AMY showed similar level of diagnostic accuracy along with sensitivity and specificity compared to DGGR lipase. In addition, P-AMY showed a significant association with CAPS score, contrary to cPL and DGGR lipase. Along with other biomarkers associated with AP, P-AMY has the potential of usefulness as a supportive diagnostic and prognostic biomarker of AP in dogs.</description><identifier>ISSN: 0165-2176</identifier><identifier>EISSN: 1875-5941</identifier><identifier>DOI: 10.1080/01652176.2024.2326007</identifier><identifier>PMID: 38497337</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Abnormalities ; Acute pancreatitis ; Amylases ; Biomarkers ; Correlation analysis ; Diagnostic systems ; Dogs ; Inflammation ; Inflammatory response ; Lipase ; Pancreas ; pancreatic-alpha amylase ; Pancreatitis ; Sensitivity analysis ; Systemic inflammatory response syndrome ; Veterinary medicine ; α-Amylase</subject><ispartof>The Veterinary quarterly, 2024-12, Vol.44 (1), p.1-7</ispartof><rights>2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024</rights><rights>2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c511t-cf0c418f9089f958e69953dadafd63df95713209a63e8324465732950c770b6a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10949834/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3140688584?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27502,27924,27925,37012,37013,44590,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38497337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Keon</creatorcontrib><creatorcontrib>Kim, Hee-hong</creatorcontrib><creatorcontrib>Joo, Jae-Beom</creatorcontrib><creatorcontrib>Kim, Ock-Kyu</creatorcontrib><creatorcontrib>Park, Sin-Wook</creatorcontrib><creatorcontrib>Suh, Guk-Hyun</creatorcontrib><creatorcontrib>Ro, Woong-Bin</creatorcontrib><creatorcontrib>Lee, Chang-Min</creatorcontrib><title>Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study</title><title>The Veterinary quarterly</title><addtitle>Vet Q</addtitle><description>Pancreatic alpha amylase (P-AMY) is used as a biomarker of acute pancreatitis (AP) in human medicine. To our knowledge, there are no studies evaluating the usefulness of P-AMY in dogs with AP. In this study, we evaluated the diagnostic value of P-AMY, currently not verified in veterinary medicine. The AP group (n = 40) consisted of dogs with AP diagnosed using clinical signs and laboratory examinations, including abnormal canine pancreatic lipase (cPL) concentration, and compatible abdominal ultrasound examination at first presentation. Evaluation of the canine AP severity (CAPS) score was performed. The control group (n = 38) was composed of normal dogs without any abnormalities in clinical findings, blood exams or diagnostic imaging. The correlation of P-AMY with cPL was confirmed by Pearson's correlation analysis (r = 0.564, p < .001). The sensitivity and specificity for the most appropriate cut-off values of P-AMY were recorded similar to the values of DGGR. The dogs with AP and CAPS ≥11 had significantly higher serum P-AMY (p = .016) contrary to DGGR lipase and cPL. Furthermore, there was a significant difference in the median P-AMY dependent on the presence of systemic inflammatory response syndrome (p = .001). P-AMY showed similar level of diagnostic accuracy along with sensitivity and specificity compared to DGGR lipase. In addition, P-AMY showed a significant association with CAPS score, contrary to cPL and DGGR lipase. Along with other biomarkers associated with AP, P-AMY has the potential of usefulness as a supportive diagnostic and prognostic biomarker of AP in dogs.</description><subject>Abnormalities</subject><subject>Acute pancreatitis</subject><subject>Amylases</subject><subject>Biomarkers</subject><subject>Correlation analysis</subject><subject>Diagnostic systems</subject><subject>Dogs</subject><subject>Inflammation</subject><subject>Inflammatory response</subject><subject>Lipase</subject><subject>Pancreas</subject><subject>pancreatic-alpha amylase</subject><subject>Pancreatitis</subject><subject>Sensitivity analysis</subject><subject>Systemic inflammatory response syndrome</subject><subject>Veterinary medicine</subject><subject>α-Amylase</subject><issn>0165-2176</issn><issn>1875-5941</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1uEzEURkcIREPhEUCW2LBJsMc_Y7OhqCpQqRIbWFt3bE_i4BkHeyZVHoD3xkPSQlmwsmSfe3yv_VXVS4JXBEv8FhPBa9KIVY1rtqppLTBuHlULIhu-5IqRx9ViZpYzdFY9y3mLMcOciafVGZVMNZQ2i-rn1R7CBKOPA4odGjcOmeAHbyCgKbtuCoPLeT7awWCSK6RBEHYbQNAfAmSHICNAQ9y7gFofe0jfXUJ-QDauM7r14waBmUb3RzD6_K6U7HyII8rjZA_PqycdhOxenNbz6tvHq6-Xn5c3Xz5dX364WRpOyLg0HTaMyE5hqTrFpRNKcWrBQmcFtWWrIbTGCgR1ktaMCd7QWnFsmga3Auh5dX302ghbvUu-dHvQEbz-vRHTWkMqEwanlbHGOoW5bGrWMtlaLkjLLBYNtpSZ4np_dO2mtnfWuGFMEB5IH54MfqPXca8JVkxJyorhzcmQ4o_J5VH3PhsXAgwuTlnXqtwlCMaqoK__QbdxSkN5K00Jw0JKLmchP1ImxZyT6-67IVjPqdF3qdFzavQpNaXu1d-j3FfdxaQAF0fAD11MPdzGFKwe4RBi6lL5Vz_38d87fgHk0dIx</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Kim, Keon</creator><creator>Kim, Hee-hong</creator><creator>Joo, Jae-Beom</creator><creator>Kim, Ock-Kyu</creator><creator>Park, Sin-Wook</creator><creator>Suh, Guk-Hyun</creator><creator>Ro, Woong-Bin</creator><creator>Lee, Chang-Min</creator><general>Taylor & Francis</general><general>Taylor & Francis Ltd</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>202412</creationdate><title>Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study</title><author>Kim, Keon ; Kim, Hee-hong ; Joo, Jae-Beom ; Kim, Ock-Kyu ; Park, Sin-Wook ; Suh, Guk-Hyun ; Ro, Woong-Bin ; Lee, Chang-Min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c511t-cf0c418f9089f958e69953dadafd63df95713209a63e8324465732950c770b6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abnormalities</topic><topic>Acute pancreatitis</topic><topic>Amylases</topic><topic>Biomarkers</topic><topic>Correlation analysis</topic><topic>Diagnostic systems</topic><topic>Dogs</topic><topic>Inflammation</topic><topic>Inflammatory response</topic><topic>Lipase</topic><topic>Pancreas</topic><topic>pancreatic-alpha amylase</topic><topic>Pancreatitis</topic><topic>Sensitivity analysis</topic><topic>Systemic inflammatory response syndrome</topic><topic>Veterinary medicine</topic><topic>α-Amylase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Keon</creatorcontrib><creatorcontrib>Kim, Hee-hong</creatorcontrib><creatorcontrib>Joo, Jae-Beom</creatorcontrib><creatorcontrib>Kim, Ock-Kyu</creatorcontrib><creatorcontrib>Park, Sin-Wook</creatorcontrib><creatorcontrib>Suh, Guk-Hyun</creatorcontrib><creatorcontrib>Ro, Woong-Bin</creatorcontrib><creatorcontrib>Lee, Chang-Min</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>The Veterinary quarterly</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Keon</au><au>Kim, Hee-hong</au><au>Joo, Jae-Beom</au><au>Kim, Ock-Kyu</au><au>Park, Sin-Wook</au><au>Suh, Guk-Hyun</au><au>Ro, Woong-Bin</au><au>Lee, Chang-Min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study</atitle><jtitle>The Veterinary quarterly</jtitle><addtitle>Vet Q</addtitle><date>2024-12</date><risdate>2024</risdate><volume>44</volume><issue>1</issue><spage>1</spage><epage>7</epage><pages>1-7</pages><issn>0165-2176</issn><eissn>1875-5941</eissn><abstract>Pancreatic alpha amylase (P-AMY) is used as a biomarker of acute pancreatitis (AP) in human medicine. To our knowledge, there are no studies evaluating the usefulness of P-AMY in dogs with AP. In this study, we evaluated the diagnostic value of P-AMY, currently not verified in veterinary medicine. The AP group (n = 40) consisted of dogs with AP diagnosed using clinical signs and laboratory examinations, including abnormal canine pancreatic lipase (cPL) concentration, and compatible abdominal ultrasound examination at first presentation. Evaluation of the canine AP severity (CAPS) score was performed. The control group (n = 38) was composed of normal dogs without any abnormalities in clinical findings, blood exams or diagnostic imaging. The correlation of P-AMY with cPL was confirmed by Pearson's correlation analysis (r = 0.564, p < .001). The sensitivity and specificity for the most appropriate cut-off values of P-AMY were recorded similar to the values of DGGR. The dogs with AP and CAPS ≥11 had significantly higher serum P-AMY (p = .016) contrary to DGGR lipase and cPL. Furthermore, there was a significant difference in the median P-AMY dependent on the presence of systemic inflammatory response syndrome (p = .001). P-AMY showed similar level of diagnostic accuracy along with sensitivity and specificity compared to DGGR lipase. In addition, P-AMY showed a significant association with CAPS score, contrary to cPL and DGGR lipase. Along with other biomarkers associated with AP, P-AMY has the potential of usefulness as a supportive diagnostic and prognostic biomarker of AP in dogs.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>38497337</pmid><doi>10.1080/01652176.2024.2326007</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-2176 |
ispartof | The Veterinary quarterly, 2024-12, Vol.44 (1), p.1-7 |
issn | 0165-2176 1875-5941 |
language | eng |
recordid | cdi_pubmed_primary_38497337 |
source | Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central |
subjects | Abnormalities Acute pancreatitis Amylases Biomarkers Correlation analysis Diagnostic systems Dogs Inflammation Inflammatory response Lipase Pancreas pancreatic-alpha amylase Pancreatitis Sensitivity analysis Systemic inflammatory response syndrome Veterinary medicine α-Amylase |
title | Evaluation of the clinical usefulness of pancreatic alpha amylase as a novel biomarker in dogs with acute pancreatitis: a pilot study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T14%3A56%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20clinical%20usefulness%20of%20pancreatic%20alpha%20amylase%20as%20a%20novel%20biomarker%20in%20dogs%20with%20acute%20pancreatitis:%20a%20pilot%20study&rft.jtitle=The%20Veterinary%20quarterly&rft.au=Kim,%20Keon&rft.date=2024-12&rft.volume=44&rft.issue=1&rft.spage=1&rft.epage=7&rft.pages=1-7&rft.issn=0165-2176&rft.eissn=1875-5941&rft_id=info:doi/10.1080/01652176.2024.2326007&rft_dat=%3Cproquest_pubme%3E3140688584%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c511t-cf0c418f9089f958e69953dadafd63df95713209a63e8324465732950c770b6a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3140688584&rft_id=info:pmid/38497337&rfr_iscdi=true |